Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
07/16/2009 | US20090183278 Novel Bacillus Thuringiensis Gene with Coleopteran Activity |
07/16/2009 | US20090183277 Novel Bacillus Thuringiensis Gene with Coleopteran Activity |
07/16/2009 | US20090183276 Novel Bacillus Thuringiensis Gene with Coleopteran Activity |
07/16/2009 | US20090183275 Nucleotide seqeunces mediating male fertility and method of using same |
07/16/2009 | US20090183273 Nucleotide sequences mediating male fertility and method of using same |
07/16/2009 | US20090183272 Nucleotide seqeunces mediating male fertility and method of using same |
07/16/2009 | US20090183269 Gene expression system using alternative splicing in insects |
07/16/2009 | US20090182512 Gene information processing apparatus and gene information display apparatus |
07/16/2009 | US20090182136 Small Internally Segmented Interfering RNA |
07/16/2009 | US20090182124 Novel transcription factor having zinc finger domains |
07/16/2009 | US20090182122 Fragments of a plant genome; controlling the expression of a gene; tools for genetic mapping; recognizing or isolating identical or related DNA fragments; identification of a particular individual organism; clustering of a group of organisms with a common trait |
07/16/2009 | US20090182121 Regulation of Human Transmembrane Serine Protease |
07/16/2009 | US20090181918 Inhibition of pathological angiogenesis in vivo |
07/16/2009 | US20090181916 Lna antagonists targeting the androgen receptor |
07/16/2009 | US20090181914 Lna oligonucleotides and the treatment of cancer |
07/16/2009 | US20090181913 SPECIFIC GRP78 EXPRESSION-INHIBITION RNAi SEQUENCE, MEDICINE THEREOF AND METHOD THEREOF |
07/16/2009 | US20090181912 GLP/1/EXENDIN 4 IgG Fc FUSION CONSTRUCTS FOR TREATMENT OF DIABETES |
07/16/2009 | US20090181911 Role of gax in alzheimer neurovascular dysfunction |
07/16/2009 | US20090181909 Vasopressin-Binding L-Nucleic Acid |
07/16/2009 | US20090181908 Methods and compositions for treating keratin hyperproliferative disorders |
07/16/2009 | US20090181907 Drug Comprising As The Active Ingredient Proliferative Vector Containing Survivin Promoter |
07/16/2009 | US20090181900 Novel peptides and methods for the treatment of inflammatory disease |
07/16/2009 | US20090181899 Low-molecular weight peptides inhibiting ion channel activity |
07/16/2009 | US20090181894 Chimeric toxins for targeted therapy |
07/16/2009 | US20090181889 Compositions and methods for detection and treatment of human herpesvirus (hhv)-6 |
07/16/2009 | US20090181884 Novel apolipoprotein gene involved in lipid metabolism |
07/16/2009 | US20090181875 Subtilase variants |
07/16/2009 | US20090181851 Promoter, Promoter Control Elements, And Combinations, And Uses Thereof |
07/16/2009 | US20090181468 Methods and compositions for treating cellular proliferative diseases |
07/16/2009 | US20090181460 Bipartite System, Method and Composition for the Constitutive and Inducible Expression of High Levels of Foreign Proteins in Plants |
07/16/2009 | US20090181459 Mouse glucocorticoid-induced tnf receptor ligand is costimulatory for t cells |
07/16/2009 | US20090181458 Tubulo-vesicular structure localization signals |
07/16/2009 | US20090181456 Adipose-derived stem cells and lattices |
07/16/2009 | US20090181455 Modulation of gene expression using insulator binding proteins |
07/16/2009 | US20090181443 Identification, cloning, expression, and a purification of three novel human calcium-independent phospholipase a2 family members possessing triacylglycerol lipase and acylglycerol transacylase activities |
07/16/2009 | US20090181435 Method for Determining L-Serine, Gene Sequene, Vectors and Micro-Organisms |
07/16/2009 | US20090181434 Transgenic photosynthetic microorganisms and photobioreactor |
07/16/2009 | US20090181429 Systems for the Expression of Orthogonal Translation Components Eubacterial Host Cells |
07/16/2009 | US20090181427 Hybrid 3' untranslated regions suitable for efficient protein expression in mammalian cells |
07/16/2009 | US20090181425 Library of Translational Fusion Partners for Producing Recombinant Proteins and Translational Fusion Partners Screened Therefrom |
07/16/2009 | US20090181424 Mammalian Expression Vector Comprising the MCMV Promoter and First Intron of HCMV Major Immediate Early Gene |
07/16/2009 | US20090181414 Retentate chromatography and protein chip arrays with applications in biology and medicine |
07/16/2009 | US20090181408 Flavin Adenine Dinucleotide-Binding Glucose Dehydrogenase |
07/16/2009 | US20090181401 Detection format for hot start real time polymerase chain reaction |
07/16/2009 | US20090181400 Method of Detection of Prostate Cancer |
07/16/2009 | US20090181399 Insect resistant coton plants and methods of detecting the same |
07/16/2009 | US20090181392 Transgenic Zebrafish Models for Neurodegenerative Diseases |
07/16/2009 | US20090181382 Sphingosine 1-Phosphate Receptor Gene, SPPR |
07/16/2009 | US20090181372 Method and compositions for monitoring DNA binding molecules in living cells |
07/16/2009 | US20090181367 Diagnosis of sepsis using mitochondrial nucleic acid assays |
07/16/2009 | US20090181124 Adding a lipid acyltransferase to the foodstuff producing an emulsifier; transferring an acyl group from a lipid to an acceptor: enhanced hydrolytic activity towards galactolipids and/or an enhanced transferase activity using galactolipid as an acyl donor |
07/16/2009 | US20090181115 Method of Screening for Compounds That Alter Skin and/or Hair Pigmentation |
07/16/2009 | US20090181091 Product and process to regulate a gene network involved in constitutive inflammation and early cancer progression |
07/16/2009 | US20090181056 Toxoplasma gondii mutant with enhanced homologous recombination and uses thereof |
07/16/2009 | US20090181051 N-linked glycosylation alteration in E1 glycoprotein of classical swine fever virus and novel classical swine fever virus vaccine |
07/16/2009 | US20090181044 Novel Flavivirus antigens |
07/16/2009 | US20090181042 Novel peptides of the respiratory syncytial virus (RSV) G protein and their use in a vaccine |
07/16/2009 | US20090181035 Plexind1 agonists and their use |
07/16/2009 | US20090181032 facilitate drug delivery of other molecules; e.g. use intraocularly in eye surgery, glaucoma, retinopathy treatments |
07/16/2009 | US20090181025 T Cell Adhesion Molecule and Antibody Thereto |
07/16/2009 | US20090181024 Novel composition and methods for the treatment of immune related diseases |
07/16/2009 | US20090181023 Nogo-a binding with enhanced affinity and pharmaceutical use thereof |
07/16/2009 | US20090181021 Ctsp Cancer-Testis Antigens |
07/16/2009 | US20090181014 Compositions and methods for the diagnosis and treatment of tumor |
07/16/2009 | US20090181013 Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereof |
07/16/2009 | US20090181009 treats hematologic malignancies, cancer; scFv antibody |
07/16/2009 | US20090181004 Modified beta-lactamase and method for its preparation |
07/16/2009 | US20090181003 Regulation of S6 Kinsase Protein Activity and Related Methods |
07/16/2009 | US20090180996 Epigenetic modification of cell phenotype, fate and/or function by RNA transfer |
07/16/2009 | US20090180995 Novel anticoagulant polypeptides and complex |
07/16/2009 | US20090180989 Compositions and methods for delivering nucleotide sequences to vertebrates |
07/16/2009 | US20090180975 Polynucleotide Fragments Of An Infectious Human Endogenous Retrovirus |
07/16/2009 | DE102008003568A1 New insulin analogs useful for treating diabetes |
07/16/2009 | CA2726928A1 Aminotransferase and oxidoreductase nucleic acids and polypeptides and methods of using |
07/16/2009 | CA2711895A1 Methods for protein production employing expression enhancer sequences derived from the rna-z segment of a comoviridae bipartite rna virus |
07/16/2009 | CA2711882A1 Improved humanized anti-human .alpha.9-integrin antibody |
07/16/2009 | CA2711863A1 Antibody directed against pcrv |
07/16/2009 | CA2711806A1 Display vectors and methods and uses thereof |
07/16/2009 | CA2711771A1 Humanized anti-a9 integrin antibodies and the uses thereof |
07/16/2009 | CA2711765A1 Conditional-stop dimerizable caspase transgenic animals |
07/16/2009 | CA2711557A1 Anti-cldn6 antibody |
07/16/2009 | CA2711497A1 Diagnostic and therapeutic methods for efmr (epilepsy and mental retardation limited to females) |
07/16/2009 | CA2711440A1 Bacillus thuringiensis gene with coleopteran inhibitory activity |
07/16/2009 | CA2711439A1 Novel bacillus thuringiensis gene with coleopteran activity |
07/16/2009 | CA2711436A1 Novel bacillus thuringiensis gene with coleopteran activity |
07/16/2009 | CA2711428A1 Method and constructs for increasing recombinant protein production in plants during dehydration stress |
07/16/2009 | CA2711417A1 Novel bacillus thuringiensis gene with coleopteran activity |
07/16/2009 | CA2711411A1 Novel bacillus thuringiensis gene with coleopteran activity |
07/16/2009 | CA2711334A1 Hemagglutinin polypeptides, and reagents and methods relating thereto |
07/16/2009 | CA2711307A1 Glycosylated protein expression in prokaryotes |
07/16/2009 | CA2711289A1 Recombinant expression plasmid vector and recombinant strain to be used in producing oxalate decarboxylase, and method of producing recombinant oxalate decarboxylase |
07/16/2009 | CA2711179A1 Rna interference for the treatment of heart failure |
07/16/2009 | CA2711147A1 Transgenic photosynthetic microorganisms and photobioreactor |
07/16/2009 | CA2711029A1 Anti mif antibodies |
07/16/2009 | CA2710922A1 Isomerases, nucleic acids encoding them and methods for making and using them |
07/16/2009 | CA2710567A1 Transgenic non-human animals expressing human blood clotting factors |
07/16/2009 | CA2710558A1 Pcv2 orf2 virus like particle with foreign amino acid insertion |
07/16/2009 | CA2710529A1 Gray leaf spot tolerant maize and methods of production |
07/16/2009 | CA2709701A1 A fluorescent two-hybrid (f2h) assay for direct visualization of protein interactions in living cells |
07/16/2009 | CA2706001A1 Method of producing sialyltransferase-modified proteins |